Survey data shows individuals are not informed on how COVID-19 could affect their conditions.
Jeremy Edwards
Advertisement
Articles by Jeremy Edwards
87% of people surveyed said they had no concerns about a decentralized approach to clinical trials.
Advertisement
Latest Updated Articles
- Recent Data Shows Positive Attitudes for Decentralized Trials in Rare Disease Patients
Published: November 13th 2020 | Updated:
Rare Disease Patients Overlooked During COVIDPublished: June 7th 2021 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
